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Abstract
This is a short summary of a meeting of the "African-Caribbean Cancer Consortium", jointly organized by the University of
Pittsburgh, Department of Epidemiology and the University of Pittsburgh Cancer Institute, held in Montego Bay, Jamaica as a
satellite meeting at the Caribbean Health Research Council, 52nd Annual Council and Scientific meeting on May 4, 2007.
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The University of Pittsburgh Graduate School of Public
Health and the University of Pittsburgh Cancer Institute
organized in Montego Bay, Jamaica a satellite meeting at
the 52nd Annual Council and Scientific meeting of the
Caribbean Health Research Council, on May 4, 2007, for
the purpose of introducing the concept of an African-Car-
ibbean Cancer Consortium (AC3) to research investigators
from the Caribbean islands, and to extend an invitation to
join the Cancer Consortium.
There were 18 attendees from various countries: Bahamas,
Barbados, Guyana, Hawaii, Jamaica, St. Kitts/Nevis, Trini-
dad and Tobago, and the United States; the majority of
whom presented or discussed their work and research
interests. All of them expressed intent to participate as
investigators in the proposed Cancer Consortium.
Participants agreed that the initial purpose of the AC3 will
be the study of viral, genetic, environmental, and lifestyle/
behavioral risk factors for cancer in populations of African
descent. The primary goal will be to provide new collabo-
rative opportunities for cancer research between the
United States, Africa, and the Caribbean. The AC3 aims to
1) address a significant need for studies related to cancer
for individuals of African descent 2) advance scientific
knowledge of the roles that viral, environmental, and
genetic risk factors play in cancer etiology among minor-
ity populations and 3) lead to targeted interventions in
order to address the existing disparity by reducing the inci-
dence and mortality rates of cancer in these minority pop-
ulations.
Existing collaborations
Several collaborations are already ongoing between US,
Caribbean and African  investigators. These include stud-
ies of prostate, breast, and cervical cancers conducted in
Africa, the Caribbean, as well as immigrant populations in
the United States (Table 1).
The work by Phillips et al. [1] was reviewed to discuss the
higher rates of cancers in the cervix, esophagus, liver, and
stomach in the Caribbean islands in comparison with the
United States. All of these cancers have been demon-
strated to be etiologically linked to, or associated, with
infectious agents. Cervical and liver cancers are associated
with Human Papillomavirus (HPV) and Hepatitis B & C
viruses respectively, while researchers are exploring the
possible associations of HPV with esophageal cancer and
Helicobacter pylori with stomach cancers [2-5]. Other
viral-cancer relationships that might be of interest to Car-
ibbean populations are Human Herpesvirus 8 (HHV8)
and prostate cancers, as well as Human T leukemia virus –
1 (HTLV1) and Adult T-cell Leukemia/lymphoma.
Table 1: Existing collaborations involving U.S., Caribbean and African Investigators
Project Location Study Investigators
University of Pittsburgh, Graduate School of Public Health
Nigeria Breast cancer Dr. Michael Okobia
Dr. Clareann Bunker
Jamaica HPV – cervical cancer Dr. Norma McFarlane-Anderson
Dr. Camille Ragin
Tobago HPV – cervical cancer Dr. Camille Ragin
Dr. Clareann Bunker
Dr. Alan Patrick
Dr. Victor Wheeler
Trinidad & Tobago HHV8 – prostate cancer Dr. Clareann Bunker
Dr. Alan Patrick
Dr. Victor Wheeler
Columbia and Long Island Universities
New York Cancer in immigrant Dr. Alfred Neugut
Caribbean populations Dr. Carol Magai
State University of New York (Stony Brook)
Barbados Barbados National Cancer Study (Prostate and Breast cancers) Dr. M. Cristina Leske
Dr. Anselm Hennis
Dr. Barbara Nemesure
Dr. Suh-Yuh Wu
Florida A & M University
USA Prostate cancer Dr. R. Renee Reams
Nigeria & USA Prostate cancer Dr. Folakemi OdedinaPage 2 of 6
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ciated viral infections in healthy Caribbean populations
was presented [6] and compared to the prevalence of each
of these viral infections in the US. For all the viruses stud-
ied, with the exception of HCV, the Caribbean had signif-
icantly higher prevalence rates than the US. For the
Caribbean, the incidence of cervical cancer ranks third
among all cancers in females (Age-standardized rate
(ASR) = 32.62/100,000), while liver cancer ranks sixth
among Caribbean females (ASR = 4.54/100,000) and fifth
among Caribbean males (ASR = 8.16/100,000) [7]. In
contrast, cervical cancer among US females is ranked 17th
for all cancers (ASR = 7.65/100,000) and for US males,
liver cancer is ranked 15th for all cancers (ASR = 5.47/
100,000) [7]. Therefore, at least for HPV and HBV infec-
tions, the elevated rates in the Caribbean appeared to fit
well with the known epidemiological information on
incidence of these cancers in the Caribbean.
Several studies have been conducted on cervical dysplasia,
cancer, and HPV infection in Jamaican women (Dr.
Norma McFarlane-Anderson, University of the West
Indies, Mona Campus). This work focused on investiga-
tions of lifestyle and genetic susceptibility factors related
to cervical dysplasia and cancer, as well as HPV prevalence
and genotype distribution among healthy Jamaican
women. The report demonstrated a high frequency of
HPV infection [8], which corresponds with the high rate
of cervical cancer in Jamaica (27.6/100,000) [9]. An HPV
vaccine for prevention of cervical cancer has been recently
approved by the Federal Drug Administration (FDA) and
targets the most common high-risk HPV types, 16 and 18.
It is expected that implementation of this vaccine would
prevent approximately 70–75% of all cervical cancers
worldwide. In Africa, Central and South America, and
Asia, a larger proportion of cervical cancer cases are asso-
ciated with HPV types other than 16 and 18 (41%–36%),
compared to the cervical cancer cases among females from
Europe, US, and Australia (~25%) [10]. Currently, there
are no data that describes the proportion of HPV16 and
HPV18-positive cervical cancer cases in the Caribbean
islands. Therefore, there is a need for additional studies in
this population, particularly now with the advent of the
new HPV vaccine. Some of the data presented by Dr.
Norma McFarlane-Anderson were generated through an
existing collaboration with US investigators, further
emphasizing the role that the AC3 could play in providing
these sorts of collaborative opportunities.
The work on prostate cancer risk in Tobago men was sum-
marized (Dr. Clareann Bunker, University of Pittsburgh
and Tobago Health Studies) [11-16]. A high rate of
Human Herpesvirus 8 (HHV8) infection in Tobago popu-
lation was observed. Dr. Clareann Bunker also reported
that short Androgen Receptor alleles have been shown to
be associated with efficient androgen metabolism. Pros-
tate cancer cases in the Tobago population were almost
three times more likely to be HHV8 positive and have
short repeat Androgen Receptor alleles than controls of
similar age. Additional studies to define the biological
mechanisms which underlie this association are ongoing.
The Barbados National Cancer Study (BNCS) (Dr. Anselm
Hennis) is a comprehensive epidemiological study of
breast and prostate cancer to determine the incidence,
environmental, and familial/genetic risk factors associ-
ated with these cancers. Some preliminary data on recruit-
ment of breast and prostate cancer cases and controls into
this study were presented. According to 2002 data from
the International Agency for Cancer Research (IARC) [7],
world-adjusted mortality rates*100,000 for prostate can-
cer are 16, 28 and 16 for W. Africa, the Caribbean, and the
US, respectively, with incidences being 19, 52 and 125.
Comparable data for breast cancer mortality is 20, 13 and
19, while incidence is 28, 33 and 101 *100,000. Dr.
Anselm Hennis reported that Barbados' incidence and
mortality rates of both cancers are the highest in the Car-
ibbean, thus strengthening the importance of studying the
African-Barbadian population.
Existing and developing cancer registries
There are to date seven established cancer registries (Baha-
mas, Cuba, Guyana, Jamaica, Martinique, Trinidad and
Tobago, and the Netherlands Antilles) as well as a prostate
cancer registry in Grenada (Table 2).
Cancer registration in Martinique has been mandatory
since 1981 and the island's cancer registry was established
in 1983 [17]. Cancer cases are identified through a
number of mechanisms: medical records, data from pri-
vate and public hospitals, laboratory records, as well as
regional insurance records of the national public medical
insurance system. For the period 1981–2000, there were
8,992 cancer cases in males and 6,832 cancer cases in
females. The highest ranking cancer type in males from
Martinique was prostate cancer (3,518 cases, world stand-
ardized incidence (WSI) = 80.83/100,000) followed by
stomach cancer (849 cases, WSI = 20.86/100,000).
Females had the highest incidence of breast cancer (1,568
cases, WSI = 35.80/100,000), followed by cervical cancer
(890 cases, WSI = 20.82/100,000).
In Cuba, the National Cancer Registry was established in
1964 and documents cancer cases through the hospital
system where the clinicians report the diagnosed cases, as
well as through the examination of death certificates [18].
This cancer registry has provided a valuable tool to evalu-
ate the burden of cancer in Cuba. The information from
the cancer registry contributed to future developments ofPage 3 of 6
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commenced in 1989 [19].
The Netherlands Antilles, formerly a Dutch colony and
now autonomous, consists of six small Caribbean islands
(Curacao, Aruba, Bonaire, Saba, St. Eustatius and St.
Maarten). A cancer registry was established in 1977 [20].
The establishment of a cancer registry in this region was
accomplished through a unique combination of condi-
tions that favored a highly reliable registration of cancer
cases. There was a centralized Pathology Laboratory, direct
access to laboratory and hospital records for critical eval-
uation of each individual case prior to registration. There
was also cooperation of hospitals and physicians.
The Dr Elizabeth Quamina National Cancer Registry of
Trinidad and Tobago (Ms Veronica Roach, Registrar) is a
resource established in 1994 by the late Dr. Elizabeth
Quamina. The registry includes data through passive and
active collection from all sources where cancer is diag-
nosed, and has the capabilities to measure the burden of
cancer in Trinidad and Tobago; determines incidence and
mortality rates for all cancers; identifies cancer clusters
and trends; informs government policies; satisfies
requests for information from medical and non medical
personnel; and disseminates information and analysis of
data to health professionals and the general public
through the publication of reports. The Trinidad and
Tobago Registry presentation was done by Dr. Alan
Patrick, on behalf of Ms. Veronica Roach. From this regis-
try, it is apparent that the top two incident cancers in
Trinidad and Tobago are prostate and colon/rectum can-
cers for males, and cervical and breast cancers for females.
This cancer registry is capable of providing data to support
cancer research priorities; however the requests for infor-
mation have been infrequent.
The cancer registry of Guyana was established in 2000
[21] as an independent body, but is now a Department of
the Ministry of Health (Dr. Wallis Plummer on behalf of
Nurse Penelope Layne, Registrar). Significant effort has
gone into enhancing the system of registration and report-
ing of cases, and both active and passive data collection is
encouraged. The registry demonstrates both alarmingly
high incidence and mortality rates of cervical, breast, and
prostate cancers. Unfortunately, despite this important
data, limited resources and a lack of expertise have pre-
vented further work from being done to investigate the
determinants of these rising cancer rates.
The Jamaican Cancer Registry was established in 1959
(Dr. Norma McFarlane-Anderson) and serves the eastern
regions of Kingston and St. Andrew. There are discussions
for the establishment of a cancer registry that will support
the western region of the island. Barbados will soon have
its own cancer registry (Dr. Anselm Hennis).
Dr. Robert Yearwood, the only urologist in Grenada, has
established a prostate cancer registry since 1996 with 300
patients to date. There have been 28 new prostate cancer
cases that have been registered since the beginning of this
year (Dr. Robert Yearwood, personal communication).
Based on a review of the pathology records, Dr. Robert
Yearwood also reported that there have been 13 cases of
breast cancer, and 10 cases of cervical and uterine cancers
diagnosed this year.
Bahamas currently has a national cancer registry (Dr.
Robin Roberts), and observations of high prostate cancer
rates in this country were reported. The Bahamas National
Cancer Registry is in its most embryonic stage, and docu-
ments only the cancers reported in the government's
health care facilities and in the government's official
health publications and reports. Very few health care pro-
viders are aware of its existence. Dr. Robin Roberts indi-
cated that there is a great need to upgrade the cancer
registry's function; expand its data base; and advance its
utility, reliability, and relevance.
Table 2: Existing cancer registries in the Caribbean
Country Type of Registry Year of Establishment Estimated Mid-Year 
Population (2007) [22]
Cuba National Cancer Registry 1964 11,416,987
Bahamas National Cancer Registry ? 305,655
Grenada Prostate Cancer Registry 1996 92,014
Guyana National Cancer Registry 2000 769,095
Jamaica Urban Cancer Registry† 1959 2,780,132
Martinique National Cancer Registry 1983 439,202
Netherlands Antilles* National Cancer Registry 1977 223,472
Trinidad and Tobago National Cancer Registry 1994 1,056,608
*Includes six Dutch-Caribbean islands (Curacao, Aruba, Bonaire, Saba, St. Eustatius and St. Maarten)
†The Jamaican cancer registration currently occurs in urban areas only (Kingston and St. Andrew).Page 4 of 6
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bean islands to have their own cancer registries. The par-
ticipants of this meeting agreed that the development of
cancer registries should be addressed at the next Consor-
tium meeting. The Cancer Registry of Trinidad and
Tobago should be used as a template in order to better
understand the issues and requirements related to the
establishment of a cancer registry, to standardize registries
throughout the Caribbean, and to allow for pan-Carib-
bean comparisons to be made.
Current limitations
Despite the amount of data generated by spontaneous
studies in the Caribbean islands, several limitations were
highlighted during this meeting. These included the lack
of data on cancer incidence and mortality from many of
the Caribbean islands. In addition, not only do the
smaller Caribbean islands lack adequate resources and/or
expertise to conduct appropriate epidemiological studies,
but many also do not have centralized reporting of new
cancer cases. Therefore, while apparent differences in can-
cer incidence in the Caribbean might be real, they could
also be due to inadequate reporting, diagnosis, and/or
screening. Due to the limited number of studies con-
ducted in the Caribbean for some cancer-associated viral
infections, such as HPV and HHV8 [6], it remains unclear
what the true overall prevalences of these viruses are in
this population. Therefore, there is a need for a nation-
wide Caribbean investigation of cancer-associated viral
prevalence. These data, along with reliable data on cancer
incidence, would improve current knowledge of regional
prevalence and would contribute to the development of
cancer prevention strategies.
Future directions
The AC3 meeting participants define the following areas as
priorities for the study of cancer in the Caribbean islands:
the need for a Cancer Control program to be written into
the Health Plans of each island in order to improve the
current knowledge of regional prevalence and to develop
cancer prevention strategies; and the need for reliable
nation-wide cancer registration in order to provide stand-
ardized data on cancer incidence and mortality through-
out the Caribbean islands.
The overall purpose of this meeting was to introduce the
concept of an African-Caribbean Cancer Consortium and
it was well received. The participants felt that the estab-
lishment of a Consortium focused on studies of individu-
als of African descent is warranted. Future AC3 goals were
presented by Dr. Camille Ragin and were as follows: 1)
the AC3 will provide a forum for the formalization and
coordination of collaborations between the investigators
from the Unites States, Caribbean, and Africa 2) the AC3
meetings will serve as a medium for these investigators to
present their data and to formally discuss the coordina-
tion of future collaborations and to seek funding to sup-
port case-control studies of cancer risk across these
populations. The next AC3 meeting is currently in the
planning stages. All of the participants who attended this
2007 meeting agreed that the definition of a clear plan for
the AC3 would be the next step that will be addressed dur-
ing the next meeting.
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